Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biohaven Pharmaceutical Holding Company (BHVN) stocks in Canada

Learn how to easily invest in Biohaven Pharmaceutical Holding Company stocks.

Biohaven Pharmaceutical Holding Company is a biotechnology business based in the US. Biohaven Pharmaceutical Holding Company stocks (BHVN.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $114.77 – an increase of 9.5% over the previous week. Biohaven Pharmaceutical Holding Company employs 825 staff and has a trailing 12-month revenue of around $307.6 million.

How to buy shares in Biohaven Pharmaceutical Holding Company

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BHVN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biohaven Pharmaceutical Holding Company stock price (NYSE:BHVN)

Use our graph to track the performance of BHVN stocks over time.

Biohaven Pharmaceutical Holding Company shares at a glance

Information last updated 2022-01-24.
Latest market close$120.54
52-week range$62.57 - $151.51
50-day moving average $119.65
200-day moving average $113.19
Wall St. target price$154.91
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-13.70

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Biohaven Pharmaceutical Holding Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Biohaven Pharmaceutical Holding Company price performance over time

Historical closes compared with the close of $120.54 from 2022-01-27

1 week (2022-01-21) 9.50%
1 month (2021-12-28) -12.29%
3 months (2021-10-28) -14.35%
6 months (2021-07-28) -5.35%
1 year (2021-01-28) 39.47%
2 years (2020-01-28) 113.57%
3 years (2019-01-28) 243.61%
5 years (2017-01-24) N/A

Biohaven Pharmaceutical Holding Company financials

Revenue TTM $307.6 million
Gross profit TTM $45.9 million
Return on assets TTM -46.17%
Return on equity TTM 0%
Profit margin -281.25%
Book value $2.09
Market capitalisation $7.8 billion

TTM: trailing 12 months

Biohaven Pharmaceutical Holding Company share dividends

We're not expecting Biohaven Pharmaceutical Holding Company to pay a dividend over the next 12 months.

Biohaven Pharmaceutical Holding Company share price volatility

Over the last 12 months, Biohaven Pharmaceutical Holding Company's shares have ranged in value from as little as $62.57 up to $151.51. A popular way to gauge a stock's volatility is its "beta".

BHVN.US volatility(beta: 1.03)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Biohaven Pharmaceutical Holding Company's is 1.0333. This would suggest that Biohaven Pharmaceutical Holding Company's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Biohaven Pharmaceutical Holding Company overview

Biohaven Pharmaceutical Holding Company Ltd. , a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

Stocks similar to Biohaven Pharmaceutical Holding Company

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site